MedMira Inc.
MIR.V
TSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -65.77% | -18.90% | -31.98% | -20.25% | -20.92% |
| Total Depreciation and Amortization | 41.20% | 159.15% | 3.56% | 6.08% | 3.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 139.06% | -- | -- | -- | -- |
| Change in Net Operating Assets | 756.13% | -62.81% | -440.00% | -110.85% | -91.12% |
| Cash from Operations | -44.70% | -150.52% | -97.94% | -271.40% | -93.75% |
| Capital Expenditure | -150.00% | -54,130.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 180.00% | -- | -- | -- |
| Cash from Investing | -150.00% | -- | -- | -- | 40.00% |
| Total Debt Issued | -- | 112.08% | 536.48% | 85.94% | 347.02% |
| Total Debt Repaid | -40.40% | 396.14% | -11.84% | -11.84% | -10.62% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -102.69% | 197.34% | 584.88% | 97.67% | 365.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -217.94% | -1,020.42% | 5,082.57% | -134.60% | 4,755.40% |
